According to a statement posted on the US Food and Drug Administration (FDA) website on Friday, FDA has approved the Emergency use Authorization (EUA) of Moderna Inc and COVID-19 vaccine, saying that the emergency licensed vaccine is suitable for people aged 18 and above.
Last week, FDA approved Pfizer Inc.This is the second experimental vaccine to be urgently licensed in the United States after the vaccine from its partner BioNTech SE.
Moderna Inc's vaccine uses new m-RNA technology similar to Pfizer Inc Biotechnology, and the effectiveness of preventing COVID-19 's symptoms is 94.1%, FDA staff said in a report on Tuesday.